CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that for the second year in a row, the company has been named in The Scientist's "Best Places to Work in Industry" survey. The company ranked second worldwide in 2012 and first worldwide in 2011.
